Author Correction: ATM inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms.
Shu J, Wang X, Yang X, Zhao G.
Sci Rep · published erratum; correction · DOI 10.1038/s41598-023-40952-6 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för KU-60019. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
24 träffarAtaxia-Telangiectasia Mutated Is Involved in Autolysosome Formation.
Hwang M, Jun DW, Song BR, Shim H, Lee CH, Kim S.
Biomol Ther (Seoul) · research-article; journal article · DOI 10.4062/biomolther.2023.003ATM inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms.
Shu J, Wang X, Yang X, Zhao G.
Sci Rep · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/s41598-023-28185-zEffects of different drugs and hormone treatment on Toxoplasma gondii glutathione S-transferase 2.
Li S, Ying Z, Xue Y, Sun Z, Liu J, Liu Q.
Parasit Vectors · research-article; journal article · DOI 10.1186/s13071-022-05589-wAtaxia Telangiectasia-Mutated Is Activated but Not Required for Productive Autographa californica Multiple Nucleopolyhedrovirus Infection.
Erickson JR, Kalejta RF, Friesen PD.
J Virol · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1128/jvi.01269-22Manipulation of Redox Metabolism Using Pharmacologic Ascorbate Opens a Therapeutic Window for Radio-Sensitization by ATM Inhibitors in Colorectal Cancer.
Callaghan CM, Abukhiran IM, Masaadeh A, Van Rheeden RV, Kalen AL, Rodman SN, Petronek MS, Mapuskar KA, George BN, Coleman MC, Goswami PC, Allen BG, Spitz DR, Caster JM.
Int J Radiat Oncol Biol Phys · research support, non-u.s. gov't; research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1016/j.ijrobp.2022.10.012Co-inhibition of ATM and ROCK synergistically improves cell proliferation in replicative senescence by activating FOXM1 and E2F1.
Yang EJ, Park JH, Cho HJ, Hwang JA, Woo SH, Park CH, Kim SY, Park JT, Park SC, Hwang D, Lee YS.
Commun Biol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/s42003-022-03658-5Inhibition of PLK3 Attenuates Tubular Epithelial Cell Apoptosis after Renal Ischemia-Reperfusion Injury by Blocking the ATM/P53-Mediated DNA Damage Response.
Deng W, Wei X, Xie Z, Zhang R, Dong Z, Zhang J, Luo Y, Cheng Q, Wang R, Li H, Na N.
Oxid Med Cell Longev · research-article; journal article · DOI 10.1155/2022/4201287Blocking ATM Attenuates SKOV3 Cell Proliferation and Migration by Disturbing <i>OGT/OGA</i> Expression <i>via hsa-miR-542-5p</i>.
Wang N, Yu M, Fu Y, Ma Z.
Front Oncol · research-article; journal article · DOI 10.3389/fonc.2022.839508Novel Diagnostic and Therapeutic Options for <i>KMT2A</i>-Rearranged Acute Leukemias.
Lopes BA, Poubel CP, Teixeira CE, Caye-Eude A, Cavé H, Meyer C, Marschalek R, Boroni M, Emerenciano M.
Front Pharmacol · research-article; journal article · DOI 10.3389/fphar.2022.749472PTEN mutant non-small cell lung cancer require ATM to suppress pro-apoptotic signalling and evade radiotherapy.
Fischer T, Hartmann O, Reissland M, Prieto-Garcia C, Klann K, Pahor N, Schülein-Völk C, Baluapuri A, Polat B, Abazari A, Gerhard-Hartmann E, Kopp HG, Essmann F, Rosenfeldt M, Münch C, Flentje M, Diefenbacher ME.
Cell Biosci · research-article; journal article · DOI 10.1186/s13578-022-00778-7Small molecule inhibition of ATM kinase increases CRISPR-Cas9 1-bp insertion frequency.
Bermudez-Cabrera HC, Culbertson S, Barkal S, Holmes B, Shen MW, Zhang S, Gifford DK, Sherwood RI.
Nat Commun · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1038/s41467-021-25415-8Caffeine disrupts ataxia telangiectasia mutated gene-related pathways and exacerbates acetaminophen toxicity in human fetal immortalized hepatocytes.
Viswanathan P, Gupta P, Sharma Y, Maisuradze L, Bandi S, Gupta S.
Toxicology · research support, non-u.s. gov't; journal article; research support, n.i.h., extramural · DOI 10.1016/j.tox.2021.152811Screening of kinase inhibitors downregulating PD-L1 expression via on/in cell quantitative immunoblots.
Xie Y, Ding J, Cui X, Wu M, Huang C, Zhang R, Wang J, Li X, Cen S, Zhou J.
Eur J Pharm Sci · journal article · DOI 10.1016/j.ejps.2019.105088Synergism between ATM and PARP1 Inhibition Involves DNA Damage and Abrogating the G<sub>2</sub> DNA Damage Checkpoint.
Mak JPY, Ma HT, Poon RYC.
Mol Cancer Ther · research support, non-u.s. gov't; journal article · DOI 10.1158/1535-7163.mct-19-0474ATM in DNA repair in cancer.
Jin MH, Oh DY.
Pharmacol Ther · research support, non-u.s. gov't; review; journal article · DOI 10.1016/j.pharmthera.2019.07.002ATM inhibition induces synthetic lethality and enhances sensitivity of PTEN-deficient breast cancer cells to cisplatin.
Li K, Yan H, Guo W, Tang M, Zhao X, Tong A, Peng Y, Li Q, Yuan Z.
Exp Cell Res · research support, non-u.s. gov't; journal article · DOI 10.1016/j.yexcr.2018.03.006Japanese apricot extract (MK615) potentiates bendamustine-induced apoptosis via impairment of the DNA damage response in lymphoma cells.
Inoue M, Honma Y, Urano T, Suzumiya J.
Oncol Lett · research-article; journal article · DOI 10.3892/ol.2017.6219A crucial role for ATR in the regulation of deoxycytidine kinase activity.
Beyaert M, Starczewska E, Van Den Neste E, Bontemps F.
Biochem Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bcp.2015.11.022Improved ataxia telangiectasia mutated kinase inhibitor KU60019 provides a promising treatment strategy for non-invasive breast cancer.
Zhu Y, Mao C, Wu J, Li S, Ma R, Cao H, Ji M, Jing C, Tang J.
Oncol Lett · retracted publication; research-article; journal article · DOI 10.3892/ol.2014.2444Pharmacokinetics, pharmacodynamics and efficacy on pediatric tumors of the glioma radiosensitizer KU60019.
Vecchio D, Daga A, Carra E, Marubbi D, Raso A, Mascelli S, Nozza P, Garrè ML, Pitto F, Ravetti JL, Vagge S, Corvò R, Profumo A, Baio G, Marcello D, Frosina G.
Int J Cancer · research support, non-u.s. gov't; journal article · DOI 10.1002/ijc.29121Predictability, efficacy and safety of radiosensitization of glioblastoma-initiating cells by the ATM inhibitor KU-60019.
Vecchio D, Daga A, Carra E, Marubbi D, Baio G, Neumaier CE, Vagge S, Corvò R, Pia Brisigotti M, Louis Ravetti J, Zunino A, Poggi A, Mascelli S, Raso A, Frosina G.
Int J Cancer · research support, non-u.s. gov't; journal article · DOI 10.1002/ijc.28680ATM kinase inhibition preferentially sensitizes p53-mutant glioma to ionizing radiation.
Biddlestone-Thorpe L, Sajjad M, Rosenberg E, Beckta JM, Valerie NC, Tokarz M, Adams BR, Wagner AF, Khalil A, Gilfor D, Golding SE, Deb S, Temesi DG, Lau A, O'Connor MJ, Choe KS, Parada LF, Lim SK, Mukhopadhyay ND, Valerie K.
Clin Cancer Res · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1158/1078-0432.ccr-12-3408Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion.
Golding SE, Rosenberg E, Valerie N, Hussaini I, Frigerio M, Cockcroft XF, Chong WY, Hummersone M, Rigoreau L, Menear KA, O'Connor MJ, Povirk LF, van Meter T, Valerie K.
Mol Cancer Ther · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1158/1535-7163.mct-09-0519